Dyadic International Inc (DYAI)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.34
- As of
Kresmion compiles this page from DYAI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
DYADIC INTERNATIONAL INC (DYAI): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-25.
See the full DYAI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for DYAI on one page. Preview it with sample data, then open it live with a free account.
Preview the DYAI dossierActive events for DYAI
- high13F: large increase
CITADEL ADVISORS LLC added +470% to DYAI (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +428% to DYAI (2026Q2)
- lowEarnings below estimates
Q3-2025: EPS $-0.06 vs $-0.0442 estimate, -0.02 on a near-zero consensus
- lowEarnings below estimates
Q4-2025: EPS $-0.058 vs $-0.0459 estimate, -0.01 on a near-zero consensus
- lowEarnings below estimates
Q1-2026: EPS $-0.05 vs $-0.0408 estimate, -0.01 on a near-zero consensus
FREE, NO ACCOUNT
Every event on DYAI, as it fires
New filings, 13F moves and cross asset events on DYAI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
DYAI positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 26745T101 · 2026Q2 | $71K | 0.00% |
| CITADEL ADVISORS LLC FundCUSIP 26745T101 · 2026Q2 | $67K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, DYAI
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
DYAI's 10-Q filed Aug 12, 2026 states:
…and management's related conclusion that there is substantial doubt about our ability to continue as a going concern for the 12 months following June 30…
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on DYAI
DYAI against its peers
DYAI's operating margin of -232.8% ranks in the 95th percentile of 9 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | DYAI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.1M USD | 1.1M USD | 65 | 12 |
| Gross margin | 24.9% | n/a | n/a | 3 |
| Operating margin | -232.8% | -1315.4% | 95 | 9 |
| Net margin | -238.3% | -1145.7% | 85 | 9 |
| Return on equity | -597.6% | -138.6% | 15 | 16 |
Peers (20): SYBX, INTI, ABOS, ADIL, BCDA, BOLT, PASG, TVRD, TCRX, CKDXF, AEON, DARE, MRKR, NEUP, KYNB, CLGN, ALLR, CLRB, NCEL, GUTS. Left out: QNTM (no annual filing), HOOK.D (period gap), VICP (period gap), CTXR (no annual filing), RADX (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (DYAI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in DYAI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on DYAI in the last 180 days.
Upstream: SEC EDGAR filings for DYAI
Kresmion, "DYADIC INTERNATIONAL INC (DYAI) institutional holdings and SEC filings", data as of 2026-09-25, https://kresmion.com/research/DYAI. Upstream data: SEC EDGAR filings for DYAI.
Link to this data (HTML):
<a href="https://kresmion.com/research/DYAI">DYADIC INTERNATIONAL INC (DYAI) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow DYAI on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to DYAI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.